Genetic Counselors Struggle For Status

Their field is blossoming, but many are disturbed by what they see as a lack of official recognition The field of medical genetics--whose practitioners are, for the most part, Ph.D.'s--recently received a significant boost by being offered member status by the American Board of Medical Specialties (ABMS), an Evanston, Ill.-based indepen- dent body that evaluates and certifies physician specialists, such as cardiologists. The prestigious ABMS hasn't admitted a new field to its 23-group roste

Written byRicki Lewis
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

The prestigious ABMS hasn't admitted a new field to its 23-group roster in 13 years, and the last time ABMS recognized Ph.D.'s, as opposed to M.D.'s, was back in 1957, when radiation physicists gained member status. With the new offer, 291 Ph.D. medical geneticists--who detect genetic problems in patients--will be on a par with obstetricians and pediatricians in that they will be able to set fees, be reimbursed by insurance companies, and not be obligated to report to M.D.'s.

But if ABMS's offer of member status comes as a pleasant surprise to Ph.D.'s, it must be a sour disappointment to another group: genetic counselors. These are the profes- sionals--most of whom hold master of science degrees--who have been specifically trained to communicate the risks of inherited disease recurrence to patients.

The field of genetic counseling officially began in 1969, when Melissa Richter, Ph.D., and Joan Marks, M.S., started the first ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies